Poor
Partially Aligned
Patient Risk:
Moderate
Summary
Some core label-consistent statements are present (e.g., approved indication for fibromyalgia and dose-related weight gain as a label concept). However, most nutrition/diet/weight-gain mechanism claims (appetite/food cravings, metabolism/insulin sensitivity, water retention/bloating, specific dietary strategies, and time-to-results) are not supported by the provided label excerpts. Several claims also over-specify magnitude/timing (e.g., “up to 10 pounds within a few months”) without label support.
Category Scores
Accurate Statements
Lyrica (pregabalin) is prescribed to treat fibromyalgia.
Section 1 INDICATIONS AND USAGE includes “Management of fibromyalgia.”
Lyrica can cause weight gain.
Section 5.8 Weight Gain: “LYRICA treatment may cause weight gain.”
Patients taking Lyrica experience an increase in body weight.
Section 5.8 Weight Gain: “LYRICA treatment may cause weight gain.” (Label concept consistent though the statement is phrased as guaranteed for “patients.”)
Unsupported Statements
Lyrica (pregabalin) is prescribed to treat epilepsy.
Provided label excerpt supports adjunctive therapy for partial-onset seizures, but does not state “epilepsy” generally.
Lyrica (pregabalin) is prescribed to treat neuropathic pain.
Label excerpts support specific neuropathic pain indications (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury), not “neuropathic pain” generically.
Lyrica can cause weight gain due to effects on appetite.
No provided label excerpt attributes weight gain to appetite or food cravings.
Lyrica can cause weight gain due to effects on metabolism.
No provided label excerpt attributes weight gain to metabolism changes.
Lyrica can cause weight gain due to effects on water retention.
No provided label excerpt attributes weight gain specifically to water retention; only peripheral edema is discussed separately (Section 5.7).
Weight gain with Lyrica can be up to 10 pounds (4.5 kg) or more within a few months of treatment.
No magnitude/timing (e.g., 10 lb within a few months) is present in the provided label excerpts.
Lyrica-related weight gain can be attributed to increased appetite and food cravings.
Not supported by provided label excerpts.
Lyrica-related weight gain can be attributed to water retention and bloating.
Not supported by provided label excerpts. (Label discusses weight gain and peripheral edema; bloating/water-retention mechanism for weight gain is not in the excerpts.)
Lyrica-related weight gain can be attributed to changes in metabolism and insulin sensitivity.
Not supported by provided label excerpts.
Lyrica-related weight gain can be attributed to a sedentary lifestyle and decreased physical activity.
Not supported by provided label excerpts.
Eating a balanced diet that promotes weight loss and overall health can help manage Lyrica-related weight gain.
No dietary management recommendations are present in the provided label excerpts.
Protein-rich foods can reduce hunger.
Not addressed in provided label excerpts.
Protein-rich foods can increase metabolism.
Not addressed in provided label excerpts.
Including protein-rich foods (lean meats, fish, eggs, tofu, and legumes) in the diet can help manage Lyrica-related weight gain.
No dietary regimen is provided in the provided label excerpts.
Choosing low-carb foods can reduce water retention and bloating.
Not addressed in provided label excerpts.
High-carb foods can exacerbate water retention and bloating.
Not addressed in provided label excerpts.
Staying hydrated can help reduce water retention and bloating.
Not addressed in provided label excerpts.
Limiting processed and high-sugar foods can exacerbate weight gain and worsen symptoms of Lyrica.
Not addressed in provided label excerpts.
The keto diet is a low-carb, high-fat diet.
Not addressed in provided label excerpts.
The keto diet can help reduce weight gain.
Not addressed in provided label excerpts.
The keto diet can improve symptoms of Lyrica.
Not addressed in provided label excerpts.
The Mediterranean diet has been shown to reduce weight gain.
Not addressed in provided label excerpts.
The Mediterranean diet can improve overall health.
Not addressed in provided label excerpts.
A low-carb diet can help reduce weight gain.
Not addressed in provided label excerpts.
A low-carb diet can improve symptoms of Lyrica.
Not addressed in provided label excerpts.
Weight loss results on a low-carb diet can vary depending on individual factors.
Not addressed in provided label excerpts.
Most people start to see results within 1-2 weeks on a low-carb diet.
Not addressed in provided label excerpts.
Contradictions
Important Omissions
Medication-specific weight-gain context from the label (e.g., weight gain relates to dose and duration of exposure) was not mentioned.
Importance:
Minor
If advising diet/monitoring for weight gain, the label excerpts provided do not include dietary management; omission of label-supported monitoring/tapering context (e.g., taper when discontinuing) is not directly relevant to the nutrition claims but is part of safe prescribing.
Importance:
Low
Safety Assessment
Potential Patient Risk:
Moderate
The label supports that pregabalin may cause weight gain, but the response adds multiple unsubstantiated mechanistic explanations and diet-based interventions with specific claims (e.g., weight gain magnitude/timing, keto/low-carb effects and timelines). These unsupported assertions could mislead patients away from label-relevant management or expectations.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Partially Aligned
Primary Issue
Most weight-gain explanation and diet/intervention claims are not supported by the provided FDA label excerpts, and the response over-specifies weight gain magnitude/timing.
Suggested Improvement
Limit statements to label-supported facts provided (e.g., approved indications for fibromyalgia and specified neuropathic pain/seizure indications; that weight gain may occur and is related to dose/duration). Remove or generalize unsupported mechanistic and dietary/timeline claims unless directly supported by the supplied label.